Gene tech bill supporters don't want to rush things

Medical research could be a big winner from GMO law reform. (Image: Malaghan Institute)

Fri, 28 Mar 2025

Supporters of the Gene Technology Bill are urging the Government to take more care around contamination risks and aligning rules with New Zealand’s markets.The bill passed its first reading in Parliament in December and is now before the health select committee, which is considering public submissions.The Government’s position is that updated rules on genetic technology will drive more progress in healthcare, lift agricultural productivity and increase exports.No application for an environmental release of a GMO has been made in NZ...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

The Quiz Free

QuiznessDesk, Friday, May 16

Can you beat the Quizmaster?

The Quizmaster 9:15am

Markets

Fletcher Building to disestablish standalone Australian division

It will switch to a trans-Tasman model.

Rebecca Howard 9:00am

Fletcher Building to disestablish standalone Australian division

Property

Townhouse sold for $275k profit in three weeks

The sale is one of a number involving a Barfoots agent and a property flipper.

Maria Slade 5:00am

Townhouse sold for $275k profit in three weeks

Sponsored

Ready for the C-Suite leap?

Part-time programme. Full-time leadership transformation.

University of Auckland Business School

Sponsored

Active beats passive in tough times

Agile investing responds faster to market shocks and shifts.

Milford

More Law & Regulation

Law & Regulation

Bronwyn Heenan: Navigating workplace romance

Romantic work relationships involve difficult conversations that should be had.

Bronwyn Heenan 5:00am

Law & Regulation

Peter Huljich is Pushpay insider trader, flagging further appeal

Rich-lister Peter Huljich has been revealed as the Pushpay executive convicted of insider trading.Huljich’s identity had been suppressed since he was charged by the Financial Markets Authority (FMA) in February 2022.The current case has been closely watched by markets as it marke...

Staff reporters 15 May 2025